- Conjunctivitis
- Hordeolum (Stye)
- Chalazion
- Blepharitis
- Iritis
- Corneal Abrasion
- Pterygium
- Subconjunctival hemorrhage
- Glaucoma
- Sjorgen's syndrome
- Macular degeneration
- Cataract
- Herpes Simplex conjunctivitis
- Herpes Zoster ophthalmicus
- Orbital cellulitis
- Age-related conditions
Showing posts with label Family. Show all posts
Showing posts with label Family. Show all posts
Saturday, October 1, 2016
Wednesday, September 28, 2016
Family med. - preventative screening
Pap smear: @21 y/o up to 70 y/o unless clinically needed.
Colonoscopy: @50 y/o unless clinically nded
Mammogram: up to 70 y/o unless clinically needed
Colonoscopy: @50 y/o unless clinically nded
Mammogram: up to 70 y/o unless clinically needed
Family med. - insurance
PPO:
- can go to any specialists anytime, no need for a referral.
- can go to any podiatrist's store at anytime and show the store the insurance card. Then, will be given free diabetics shoes (if the store has diabetics shoes)
HMO:
- need referral from PCP even for diabetics shoes
Common Family meds Rx for NP students
- Immunization
HepA - 2-dose series for travelers, usu. those coming from Southeast Asian may not need it since they usually already have the immunity
HepB - Engerix 1mL - VIS Feb 02 2012 - 3-dose series
HPV - 3 dose series
HepB - Engerix 1mL - VIS Feb 02 2012 - 3-dose series
HPV - 3 dose series
Tdap 0.5mL - VIS Feb 24 2015 - once every 10 years
Fluvirin (flu vax for <65 y/o) - VIS 08-07-2015 - once every year starting Sep
Fluad (flu vax for >65y/o) - once every year starting Sep
Pneumovax (pneumonia for >=65 y/o) - once every q5 yrs
Prevnar (pneumonia for >=65 y/o) - once in a lifetime
Fluad (flu vax for >65y/o) - once every year starting Sep
Pneumovax (pneumonia for >=65 y/o) - once every q5 yrs
Prevnar (pneumonia for >=65 y/o) - once in a lifetime
Zostavax - once every 10 years
- TB screen
TB 0.1mL or 10 units in insulin syringe
- Insomnia
Hydroxyzine 25mg take PO QHS PRN 30 pills No refills
- Hyperlipidemia
Atorvastatin 20 or 40mg
- Hypertension
Losartan 50mg
- Rash
Mild: Triamcinolone 80mcg x2 times a day 1 application to the affected area 2x daily
Severe: Fluocinolone
Fungal: Clotrimazole 1% & Betamethasone 0.05% 45g
- Allergy
Loratadine 10mg 1 tab daily 30 tabs
Fluticasone 50mcg 2 sprays nasal daily refill:2 Quantity:1
- Inflammation pain
Ibuprofen 400 mg 240tabs
(Children: 154lbs/2.2 = 70kg *10 = 700mg)
- Cough
Promethazine DM
Benzonatate (Tenson Perles) 200mg oral capsule 1 capsul PO q8hrs pprn Refill: 0 Quantity: 60 pills
- Severe nasal Nasal d/c unrelieved with Flonase nasal spray & Loratadine:
Triprolidine & Pseudoephedrine (Aprodine) 2.5-60 MG Oral Tablet Sig: 1 tab po qhs prn
- Restless leg syndrome
Ropiniole 0.5mg tabs - 0.25mgx2, 0.5mgx3. RTCin 1 week for evaluation
- Antiemetic patch
Scopolamine patch good for 72 hrs
- Menopause symptoms
Estroven OTC
Sunday, September 18, 2016
TB 2-step skin test
In some persons infected with TB, especially older persons, the ability to mount a positive TST reaction may wane over time. An initial TST placed in these individuals may not fully react, and be interpreted as negative. However, a repeat TST within a year or more may react and show a positive reaction. This effect is known as the booster phenomenon, and a positive “boosted” response should be considered the valid baseline for that individual. In a person who has never been infected with TB (assuming no BCG vaccination or non-TB mycobacterial infection), repeated TST testing itself will not elicit a positive reaction.
Two-step testing is a screening method that takes into account a possible booster phenomenon in an individual and should be considered for any person when serial testing is to occur. While boosting is most common in persons aged 55 or older, some employers who require TB screening utilize a two-step test for all new employees regardless of age while others select an age cut-off point of usually 45 to 55 years to reduce the likelihood that a boosted reaction is not misinterpreted as a recent conversion.
Candidates for two-step TST include employees of health care facilities, employees who undergo periodic TB screening, and residents of congregate living settings (details for screening those populations are described in Chapter Seven, page 7-7). Two-step testing should be performed only for initial TB screening. Subsequent periodic testing requires only one TST. Therefore, an individual who can provide documentation of a negative TST by the Mantoux technique within the preceding year has no need for two-step testing, as it is very unlikely the TST result is the result of waning immunity.
Procedure and interpretation for two-step skin testing (see Figure 2-1, page 2-17):
1. Administer the Mantoux TST.
2. Examine the TST in 48 to 72 hours. If initial TST is negative, repeat TST within one to three weeks using the same dose and strength of tuberculin and have patient return in 48 to 72 hours for the second reading. A positive TST means the individual is considered infected, and should be evaluated for treatment of LTBI.
OR
As an alternative, the initial TST can be examined in seven days, since a truly positive TST persists for many days beyond 72 hours. If the initial TST is negative, a repeat TST can be administered at the same visit and the individual should be instructed to return in 48 to 72 hours for the second reading. A positive TST means the individual is considered infected, and should be evaluated for treatment of LTBI.
Source: http://publichealth.lacounty.gov/tb/forms/chapter2.pdf (page 15)
Two-step testing is a screening method that takes into account a possible booster phenomenon in an individual and should be considered for any person when serial testing is to occur. While boosting is most common in persons aged 55 or older, some employers who require TB screening utilize a two-step test for all new employees regardless of age while others select an age cut-off point of usually 45 to 55 years to reduce the likelihood that a boosted reaction is not misinterpreted as a recent conversion.
Candidates for two-step TST include employees of health care facilities, employees who undergo periodic TB screening, and residents of congregate living settings (details for screening those populations are described in Chapter Seven, page 7-7). Two-step testing should be performed only for initial TB screening. Subsequent periodic testing requires only one TST. Therefore, an individual who can provide documentation of a negative TST by the Mantoux technique within the preceding year has no need for two-step testing, as it is very unlikely the TST result is the result of waning immunity.
Procedure and interpretation for two-step skin testing (see Figure 2-1, page 2-17):
1. Administer the Mantoux TST.
2. Examine the TST in 48 to 72 hours. If initial TST is negative, repeat TST within one to three weeks using the same dose and strength of tuberculin and have patient return in 48 to 72 hours for the second reading. A positive TST means the individual is considered infected, and should be evaluated for treatment of LTBI.
OR
As an alternative, the initial TST can be examined in seven days, since a truly positive TST persists for many days beyond 72 hours. If the initial TST is negative, a repeat TST can be administered at the same visit and the individual should be instructed to return in 48 to 72 hours for the second reading. A positive TST means the individual is considered infected, and should be evaluated for treatment of LTBI.
Source: http://publichealth.lacounty.gov/tb/forms/chapter2.pdf (page 15)
Family practice coding/billing
TB screening:
icd 10 Z11.1 ENCOUNTER FOR SCREENING FOR RESPIRATORY TUBERCULOSIS
VIS (Vaccine Information Statement) for flu shot: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/flu.pdf see date at the bottom: 08/07/2015
icd 10 Z11.1 ENCOUNTER FOR SCREENING FOR RESPIRATORY TUBERCULOSIS
cpt86580 | SKIN TEST; TUBERCULOSIS, INTRADERMA |
Ovarian cyst: icd 10
|
Subscribe to:
Posts (Atom)